Jupiter Asset Management Ltd. Purchases 18,047 Shares of Chemed Corporation $CHE

Jupiter Asset Management Ltd. lifted its stake in Chemed Corporation (NYSE:CHE) by 35.0% during the second quarter, HoldingsChannel reports. The firm owned 69,563 shares of the company’s stock after purchasing an additional 18,047 shares during the period. Jupiter Asset Management Ltd.’s holdings in Chemed were worth $33,872,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in CHE. Renasant Bank boosted its holdings in shares of Chemed by 2.3% in the 1st quarter. Renasant Bank now owns 815 shares of the company’s stock valued at $501,000 after buying an additional 18 shares in the last quarter. Cim LLC lifted its holdings in Chemed by 1.0% during the first quarter. Cim LLC now owns 2,029 shares of the company’s stock valued at $1,248,000 after purchasing an additional 21 shares in the last quarter. Cynosure Group LLC lifted its stake in Chemed by 4.3% in the 1st quarter. Cynosure Group LLC now owns 581 shares of the company’s stock worth $358,000 after purchasing an additional 24 shares in the last quarter. Atria Investments Inc increased its position in shares of Chemed by 0.6% during the second quarter. Atria Investments Inc now owns 4,259 shares of the company’s stock valued at $2,074,000 after acquiring an additional 25 shares during the last quarter. Finally, Brogan Financial Inc. raised its stake in shares of Chemed by 7.3% in the first quarter. Brogan Financial Inc. now owns 426 shares of the company’s stock valued at $262,000 after acquiring an additional 29 shares in the last quarter. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Insider Buying and Selling

In other news, Director Patrick P. Grace sold 150 shares of the firm’s stock in a transaction that occurred on Tuesday, September 9th. The shares were sold at an average price of $463.39, for a total value of $69,508.50. Following the sale, the director directly owned 3,397 shares in the company, valued at approximately $1,574,135.83. This trade represents a 4.23% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Kevin J. Mcnamara sold 3,000 shares of Chemed stock in a transaction that occurred on Friday, September 26th. The stock was sold at an average price of $461.28, for a total transaction of $1,383,840.00. Following the sale, the chief executive officer owned 96,197 shares in the company, valued at approximately $44,373,752.16. This represents a 3.02% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 3.29% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on the stock. Bank of America reduced their target price on shares of Chemed from $610.00 to $595.00 and set a “buy” rating for the company in a report on Wednesday, September 10th. Oppenheimer decreased their target price on Chemed from $650.00 to $580.00 and set an “outperform” rating for the company in a report on Thursday, July 31st. Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a research report on Thursday, October 30th. Weiss Ratings reissued a “hold (c-)” rating on shares of Chemed in a report on Wednesday, October 8th. Finally, Jefferies Financial Group upgraded shares of Chemed from a “hold” rating to a “buy” rating and raised their price objective for the company from $490.00 to $550.00 in a research note on Tuesday, September 2nd. Four analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $574.25.

Chemed Trading Up 0.4%

NYSE CHE opened at $447.18 on Thursday. Chemed Corporation has a 1-year low of $408.42 and a 1-year high of $623.60. The company has a 50 day moving average of $444.87 and a 200-day moving average of $485.34. The firm has a market cap of $6.33 billion, a price-to-earnings ratio of 23.65, a PEG ratio of 2.69 and a beta of 0.43.

Chemed (NYSE:CHE) last posted its quarterly earnings results on Tuesday, October 28th. The company reported $5.27 earnings per share for the quarter, missing analysts’ consensus estimates of $5.39 by ($0.12). The business had revenue of $624.90 million for the quarter, compared to the consensus estimate of $626.04 million. Chemed had a return on equity of 25.89% and a net margin of 11.02%.The company’s quarterly revenue was up 3.1% on a year-over-year basis. During the same period last year, the firm earned $5.64 earnings per share. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. On average, analysts forecast that Chemed Corporation will post 21.43 earnings per share for the current year.

Chemed Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, December 5th. Shareholders of record on Monday, November 17th will be paid a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date is Monday, November 17th. Chemed’s dividend payout ratio (DPR) is currently 12.69%.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.